Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mohs Micrographic Surgery for Primary Cutaneous Malignant Melanoma In Situ Using Immunofluorescence

NCT02306512 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT02306512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02306512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mohs Micrographic Surgery for Primary Cutaneous Malignant Melanoma In Situ Using Immunofluorescence
Lead sponsor
University of Miami
Phase
Not applicable
Overall status
Withdrawn
Start date
June 30, 2015
Completion date
November 30, 2015
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lentigo maligna, melanoma in situ